Return the serovar in mo_shortname() for Salmonella, keep Salmonella groups apart from streptococci, abbreviate all Lancefield groups, and apply the Typhi rule in mdro() (#341)

This commit is contained in:
dr. M.S. (Matthijs) Berends committed 2026-11-04 07:57:20 +01:00
1 parent 08fd165a60
commit 3b8b213616
7 files changed
+60 -9

No files matched your search

+6 -1
View File
@@ -1,7 +1,12 @@
# AMR 3.1.0.9014
# AMR 3.1.0.9015
This version fixes a critical bug in WISCA that biased all coverage estimates of `wisca()` and `antibiogram(..., wisca = TRUE)` downwards since AMR 3.0.0. Users are strongly advised to re-run their WISCA analyses.
### Breaking
* `mo_shortname()` now returns the serovar for *Salmonella* serovars, e.g., `"S. Typhi"` and `"S. Goldcoast"` instead of `"S. enterica"`. As this is the default for `bug_drug_combinations()` and short names in `antibiogram()`, serovars are no longer merged in their results. Use `FUN = function(x) paste(mo_genus(x), mo_species(x))` in `bug_drug_combinations()` to group them by species (#341)
* `mo_shortname()` now returns e.g. `"S. Group B"` for *Salmonella* groups instead of the abbreviations of streptococci, such as `"GBS"`, so that they are no longer merged with streptococci in `bug_drug_combinations()` and `antibiogram()`. *Streptococcus* groups E, I, J and L are now also abbreviated, e.g., `"GES"`, and `"B_STRPT_ABCG"` now returns `"S. Group A, B, C, G"` instead of the malformed `"GA, B, C, GS"` (#341)
* `mdro()` now applies the rule for *Salmonella* Typhi in the EUCAST guidelines, i.e., resistance to carbapenems (and fluoroquinolones in `"EUCAST3.1"`). This rule never applied before, so these isolates were wrongly classified as negative (#341)
### Changed
* WISCA (`wisca()` and `antibiogram(..., wisca = TRUE)`)
* Fixed a critical bug that systematically underestimated the coverage of every WISCA since AMR 3.0.0. Pathogens absent from a syndromic group, and pathogens without any test result for a regimen, were still included in the model with only prior information: each added a prior weight of 1 to the pathogen incidence, and untested pathogens kept their full incidence weight while counting as about 50% susceptible. The bias was largest for stratified analyses (e.g., up to 14 percentage points for meropenem in random strata of `example_isolates`). Now, only pathogens that occur in a group and have at least one test result for the regimen are included. Please re-run all WISCA analyses (#337)